1.17
Geovax Labs Inc Borsa (GOVX) Ultime notizie
GOVX Q1 2026 Earnings: EPS Surprise of 41.89% as Loss Narrows from EstimatesConsensus Forecast Report - newsline.com
GeoVax Labs (GOVX) could find a support soon, here's why you should buy the stock now - MSN
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
GeoVax Labs Company Profile & Introduction - Moomoo
[SCHEDULE 13G] GeoVax Labs, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Why Is GOVX Stock Falling Today? - Stocktwits
Q3 2025 GeoVax Labs Inc Earnings Call Transcript - GuruFocus
GeoVax Highlights Research Showing Gedeptin Could Enhance Checkpoint Inhibitor Responses in Resistant Tumors - MEXC
GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses - Yahoo Finance
GOVX Q1 2026 Earnings: EPS Surprises to the Upside, Yet Stock Retreats 11.8%EPS Surprise History - newsline.com
GEOVAX LABS INC (GOVX) Stock Chart - ChartMill
[EFFECT] GeoVax Labs, Inc. SEC Filing - Stock Titan
GeoVax Labs | EFFECT: Others - Moomoo
GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax CEO Sees Renewed Strategic Focus on Vaccine Platforms Amid Industry Acquisitions - citybuzz -
GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation - Yahoo Finance
GeoVax CEO Highlights Biothreat Readiness as FIFA World Cup 2026 Approaches - MEXC
GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness - Yahoo Finance
Why is GeoVax Labs stock falling Tuesday? - MSN
GOVX Q1 2026 Earnings: Narrower-than-Expected Loss as Biotech Advances DevelopmentEarnings Growth Forecast - newsline.com
GOVX: GEO-MVA advances to phase III with expedited EMA review, targeting unmet global vaccine demand - TradingView
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), GeoVax Labs (GOVX) and Vir Biotechnology (VIR) - The Globe and Mail
GeoVax CEO to Discuss Platform-Based Vaccine Technologies in Tribe Public Webinar - citybuzz -
Registration Now Open for Tribe Public CEO Presentation and Q&A Webinar Event - NewMediaWire
GeoVax Labs Inc. (GOVX) Q1 2026 Earnings: Narrower-Than-Expected Loss, No Revenue; Shares SlidePre-Announcement Alert - newsline.com
GOVX Q1 2026 Earnings: Narrower-than-Expected Loss Surprises MarketTech Earnings Analysis - The Legal Advocate
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW! - FinancialContent
GeoVax Labs (GOVX) Narrows Focus on Key Development Programs - GuruFocus
GOVX Faces 11% Decline Following Suspension of COVID Vaccine Ini - GuruFocus
GeoVax Labs (GOVX) Shifts Focus from COVID Vaccine to Smallpox P - GuruFocus
GeoVax Prioritizes GEO-MVA and Gedeptin, Discontinues COVID-19 Vaccine Development - citybuzz -
GeoVax (GOVX) resale S-1 shows 7.6M warrant shares and tight cash runway - Stock Titan
GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R) - Yahoo Finance
How The GeoVax Labs (GOVX) Story Is Shifting With Vaccine Progress And Funding Risks - Yahoo Finance
Roth MKM Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
GOVX Q1 2026 Earnings: Narrower Loss Surprises, Shares Surge Over 32%Earnings Call Q&A - The Legal Advocate
GOVX Jumps As GeoVax Wins Bullish Ebola Vaccine Call - timothysykes.com
Geovax Labs Analyst Ratings and Price Targets | NASDAQ:GOVX - Benzinga
Geovax Labs Inc (GOVX) Stock Price, Quote, News & History - Benzinga
GOVX Stock Jumps As Noble Capital Targets $10 On Ebola Vaccine Hopes - StocksToTrade
GOVX Stock Jumps As Noble Capital Reaffirms $10 Target - timothysykes.com
GeoVax Labs Q1 2026 Earnings: Significant EPS Beat Drives Stock SurgeRevenue Surprise History - Newser
Q1 2025 GeoVax Labs Inc Earnings Call Transcript - GuruFocus
Is GeoVax Labs (GOVX) Still a Buy After +15.92% Rally? 2026-05-20Trading Community - Newser
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats - Benzinga
GeoVax Highlights Need for Flexible Vaccine Platforms Amid Bundibugyo Ebola Outbreak - MEXC
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms - Yahoo Finance
GeoVax Labs Announces Private Placement Offering with Pre-Funded and Common Stock Purchase Warrants – Details and Agreements Included - Minichart
GeoVax Raises $3 Million via Private Placement Financing - TipRanks
GeoVax Raises $2.7 Million Net in Private Placement of Pre-Funded and Common Warrants - TradingView
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):